The funds will support expanded commercialization of the company’s baroreflex activation stimulation technology to treat heart failure in patients with a low left-ventricular ejection fraction.
CVRx plans to raise up to $75m in an initial public offering and plans to be listed on Nasdaq under the ticker CVRX.
The Minneapolis company markets Barostim Neo, the second-generation of its implantable baroreflex activation stimulator. It remains the only commercially available neuromodulation device indicated to improve symptoms for patients suffering heart...
The brunt of the tariff exposure stems from Singapore and Costa Rica, which together account for an estimated 70% to 80% of the tariff-related cost burden. Less than 10% of the exposure is tied to China.
A study from Babson Diagnostics published in the peer-reviewed Journal of Applied Laboratory Medicine showed that capillary blood sample volume issues can overcome historical challenges, such as poor quality, through a technique called assay miniaturization.
The UK has issued clearer guidance to help drug and medical device sponsors demonstrate how they intend to include a diverse and relevant range of participants in their clinical trials.
